Covered recipient · General Payments record
YADIRA LOPEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,282.78
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $668.50 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $246.52 | 18 |
| Merck Sharp & Dohme Corporation | $113.77 | 1 |
| BARD PERIPHERAL VASCULAR, INC. | $71.74 | 1 |
| Smith & Nephew, Inc. | $45.43 | 3 |
| E.R. Squibb & Sons, L.L.C. | $44.67 | 3 |
| Mozarc Medical US LLC | $38.91 | 1 |
| W. L. Gore & Associates, Inc. | $33.92 | 1 |
| Novo Nordisk AS | $25.00 | 1 |
| Kiniksa Pharmaceuticals International, plc | $16.66 | 1 |
| Lilly USA, LLC | $16.51 | 1 |
| CashFlow Solutions, LLC | $15.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.45 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555628 | CMS |
| ABBVIE INC. | $13.81 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555630 | CMS |
| ABBVIE INC. | $16.32 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555632 | CMS |
| ABBVIE INC. | $12.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555634 | CMS |
| ABBVIE INC. | $16.55 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555636 | CMS |
| ABBVIE INC. | $14.07 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555638 | CMS |
| ABBVIE INC. | $16.90 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555640 | CMS |
| ABBVIE INC. | $11.50 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555642 | CMS |
| ABBVIE INC. | $12.42 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555644 | CMS |
| ABBVIE INC. | $15.85 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555646 | CMS |
| ABBVIE INC. | $18.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555648 | CMS |
| ABBVIE INC. | $10.54 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555650 | CMS |
| ABBVIE INC. | $10.18 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555652 | CMS |
| ABBVIE INC. | $12.46 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555654 | CMS |
| ABBVIE INC. | $12.50 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555656 | CMS |
| ABBVIE INC. | $14.31 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555658 | CMS |
| ABBVIE INC. | $14.21 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555660 | CMS |
| ABBVIE INC. | $9.48 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107555662 | CMS |
| Bard Peripheral Vascular, Inc. | $71.74 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128482815 | CMS |
| CashFlow Solutions, LLC | $15.37 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139261997 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101382384 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101382396 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.15 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101382442 | CMS |
| Kiniksa Pharmaceuticals International, plc | $16.66 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154855767 | CMS |
| Lilly USA, LLC | $16.51 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135974812 | CMS |
| Merck Sharp & Dohme LLC | $113.77 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141795078 | CMS |
| Mozarc Medical US LLC | $38.91 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141014085 | CMS |
| Novo Nordisk Inc | $25.00 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100614587 | CMS |
| Smith+Nephew, Inc. | $16.89 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149585894 | CMS |
| Smith+Nephew, Inc. | $15.40 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149585892 | CMS |
| Smith+Nephew, Inc. | $13.14 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149585890 | CMS |
| W. L. Gore & Associates, Inc. | $33.92 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148076965 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.